Aarti Pharmalabs Limited (NSE:AARTIPHARM)

Aarti Pharmalabs Statistics

Total Valuation

NSE:AARTIPHARM has a market cap or net worth of INR 83.97 billion. The enterprise value is 87.53 billion.

Market Cap	83.97B
Enterprise Value	87.53B

Important Dates

The next estimated earnings date is Tuesday, October 28, 2025.

Earnings Date	Oct 28, 2025
Ex-Dividend Date	Sep 15, 2025

Share Statistics

NSE:AARTIPHARM has 90.64 million shares outstanding. The number of shares has increased by 0.05% in one year.

Current Share Class	90.64M
Shares Outstanding	90.64M
Shares Change (YoY)	+0.05%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	29.03%
Owned by Institutions (%)	20.55%
Float	47.96M

Valuation Ratios

The trailing PE ratio is 31.53.

PE Ratio	31.53
Forward PE	n/a
PS Ratio	4.32
PB Ratio	4.22
P/TBV Ratio	4.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	32.85
EV / Sales	4.50
EV / EBITDA	18.94
EV / EBIT	23.54
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.21
Debt / EBITDA	0.89
Debt / FCF	n/a
Interest Coverage	12.95

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	10.51%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	9.00M
Profits Per Employee	1.23M
Employee Count	2,162
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:AARTIPHARM has paid 860.15 million in taxes.

Income Tax	860.15M
Effective Tax Rate	24.40%

Stock Price Statistics

The stock price has increased by +37.33% in the last 52 weeks. The beta is -0.50, so NSE:AARTIPHARM's price volatility has been lower than the market average.

Beta (5Y)	-0.50
52-Week Price Change	+37.33%
50-Day Moving Average	887.47
200-Day Moving Average	772.64
Relative Strength Index (RSI)	62.44
Average Volume (20 Days)	367,293

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:AARTIPHARM had revenue of INR 19.46 billion and earned 2.66 billion in profits. Earnings per share was 29.38.

Revenue	19.46B
Gross Profit	9.75B
Operating Income	3.74B
Pretax Income	3.52B
Net Income	2.66B
EBITDA	4.64B
EBIT	3.74B
Earnings Per Share (EPS)	29.38

Balance Sheet

The company has 562.06 million in cash and 4.13 billion in debt, giving a net cash position of -3.57 billion or -39.38 per share.

Cash & Cash Equivalents	562.06M
Total Debt	4.13B
Net Cash	-3.57B
Net Cash Per Share	-39.38
Equity (Book Value)	19.90B
Book Value Per Share	219.62
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 50.11%, with operating and profit margins of 19.20% and 13.69%.

Gross Margin	50.11%
Operating Margin	19.20%
Pretax Margin	18.11%
Profit Margin	13.69%
EBITDA Margin	23.84%
EBIT Margin	19.20%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.54%.

Dividend Per Share	5.00
Dividend Yield	0.54%
Dividend Growth (YoY)	66.67%
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	-0.05%
Shareholder Yield	0.49%
Earnings Yield	3.17%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2